MAPKAPK5 and neoplasm: Tumours with 1‐3 regional nodal metastatic lesions (N1) showed slightly higher expression of TLK1, but significant upregulation of MK5 compared to tumours with no nodal metastatic lesion (N0) (Fig. 6B and C) was observed.